PhD students, postdoctoral fellows and lab technicians are being recruited for the new laboratories at Peking University and Chinese Institute For Brain Research.
Work in the unit will focus on understanding the functions and signaling mechanisms of neuronal growth factors and their receptors in neuronal function and connectivity, neurodegeneration and in metabolic regulation, for the development of better therapies to diseases of the nervous system and metabolic disorders.
Candidates with expertise in cellular, molecular or structural biology, drug development, neurobiology, metabolism, adipose tissue and mouse genetics are encouraged to apply.
Applications, including CV, list of publications and statement of research interests should be sent by email to Prof. Carlos Ibanez: Applicants should arrange to have at least two confidential letters of reference sent independently by referees to this email address.
Yunxi Zhang has a Bachelor in Veterinary Medicine from Beijing University Of Agriculture and several internships, including the Institute of Biophysics at the Chinese Academy Of Science. She joins the CIBR unit to take care of our mouse colonies including genotyping and colony management.
Yiqiao Wang took a PhD in neuroscience in 2019 at the Karolinska Institute in Stockholm, Sweden. His doctoral thesis was on studies of the early specification and diversification of sensory neurons in the peripheral nervous system, exploring different aspects of developmental neurobiology, from early progenitors to axon growth and terminal selection of synaptic partners. During this research, he made use of various in vitro and in vivo models and technologies, using mouse genetics, molecular cloning, cell culture, histology work and did few animal behavior experiments. His work resulted in several articles in journals such as Cell Reports, Scientific Reports, Nature Communications and Development. Yiqiao will conduct research at the new units at PKU and CIBR, and assist in training of students and lab management tasks.
Starting in January 2020, new laboratories dedicated to studies of growth factor receptor signaling and physiology will be established at the McGovern Institute of the School of Life Sciences in Peking University, and the Chinese Institute for Brain Research in Beijing, China. The research activities of the PKU and CIBR labs will run in parallel to and complement with those ongoing at the laboratories in Karolinska Institute and National University of Singapore. The initial focus of the Beijing labs will be on studies of death receptor signaling in neurodegeneation, metabolic regulation by activin receptors, control of brain microvasculature integrity and function by neurotrophin receptors, and a drug discovery program targeted to these receptors. PhD students, postdoctoral fellows and lab technicians are being recruited for the new Beijing laboratories. For details and how to apply, visit the Open Positions page.